Novartis (NVS) P/FCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 15.6 | 16.2 | 17.9 | 14.2 | 15.1 | 17.3 | |||
| Changes by years, y/y, % | -9% | +4% | +11% | -21% | +6% | -3.8% | |||
Novartis. P/FCF
Novartis. P/FCF, changes, %
Novartis (NVS) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | 14.8 | 14.0 | 14.0 | 16.9 | 17.8 | 17.3 | ||
| Changes by years, y/y, % | -16% | -18% | -22% | +20% | +21% | |||
| Changes by quarters, q/q, % | +6% | -5% | 0% | +20% | +6% | |||